{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05190744",
            "orgStudyIdInfo": {
                "id": "21-005437"
            },
            "organization": {
                "fullName": "Mayo Clinic",
                "class": "OTHER"
            },
            "briefTitle": "PB to Treat Hereditary Nephrogenic Diabetes Insipidus, ADPKD Treated With Tolvaptan, and Severely Polyuric Patients With Previous Lithium Administration",
            "officialTitle": "A Multi-center, Open-Label, Exploratory Study to Assess the Efficacy of PB in Decreasing the Urine Output and Increasing the Urine Osmolality in Patients With Hereditary Nephrogenic Diabetes Insipidus, Patients With Autosomal Dominant Polycystic Kidney Disease Treated With Tolvaptan, And Severely Polyuric Patients With Previous Lithium Administration (Serendipity-PB1)",
            "acronym": "SerendipityPB1",
            "therapeuticArea": [
                "Endocrinology",
                "Nephrology and Renal Diseases"
            ],
            "study": "pb-to-treat-hereditary-nephrogenic-diabetes-insipidus-adpkd-treated-with-tolvaptan-and-severely-polyuric-patients-with-previous-lithium-administration"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-04",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2022-09-01",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-09-30",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2025-12-31",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2021-12-29",
            "studyFirstSubmitQcDate": "2021-12-29",
            "studyFirstPostDateStruct": {
                "date": "2022-01-13",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-04-18",
            "lastUpdatePostDateStruct": {
                "date": "2024-04-22",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "PRINCIPAL_INVESTIGATOR",
                "investigatorFullName": "Fouad T. Chebib",
                "investigatorTitle": "Principal Investigator",
                "investigatorAffiliation": "Mayo Clinic"
            },
            "leadSponsor": {
                "name": "Mayo Clinic",
                "class": "OTHER"
            },
            "collaborators": [
                {
                    "name": "Hopital du Sacre-Coeur de Montreal",
                    "class": "OTHER"
                }
            ]
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "The purpose of this research is to study the effectiveness and safety of the medication PB in slowing the frequent urination related to tolvaptan as long-term treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD), or frequent urination related to inherited nephrogenic diabetes insipidus as an inherited condition or as an acquired condition from prior treatment with lithium."
        },
        "conditionsModule": {
            "conditions": [
                "Autosomal Dominant Polycystic Kidney Disease",
                "Nephrogenic Diabetes Insipidus",
                "Acquired Nephrogenic Diabetes Insipidus",
                "Congenital Nephrogenic Diabetes Insipidus"
            ],
            "keywords": [
                "Tolvaptan",
                "ADPKD",
                "Polycystic Kidney Disease",
                "NDI",
                "Nephrogenic diabetes insipidus",
                "Inherited nephrogenic diabetes insipidus",
                "Diabetes Insipidus",
                "Lithium",
                "Lithium-induced nephrogenic diabetes insipidus",
                "Vasopressin receptor antagonist",
                "Tolvaptan-induced aquaresis"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE2"
            ],
            "designInfo": {
                "allocation": "NON_RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "SUPPORTIVE_CARE",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 20,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Polyuric subjects with Hereditary Nephrogenic Diabetes Insipidus",
                    "type": "EXPERIMENTAL",
                    "description": "Polyuric subjects with hereditary nephrogenic diabetes insipidus with loss of function of arginine vasopressin receptor 2 (AVPR2) or aquaporin 2 (AQP2) will be treated with PB",
                    "interventionNames": [
                        "Drug: PB"
                    ]
                },
                {
                    "label": "Polyuric subjects with Autosomal Dominant Polycystic Kidney Disease treated with Tolvaptan",
                    "type": "EXPERIMENTAL",
                    "description": "Polyuric subjects with autosomal dominant polycystic kidney disease on chronic tolvaptan treatment will be treated with PB",
                    "interventionNames": [
                        "Drug: PB"
                    ]
                },
                {
                    "label": "Polyuric subject secondary to lithium administration",
                    "type": "EXPERIMENTAL",
                    "description": "Polyuric subject post lithium administration will receive PB",
                    "interventionNames": [
                        "Drug: PB"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "PB",
                    "description": "500mg twice daily (BID) followed by 1000mg BID. The dose of PB inducing the maximal increase in urine osmolality will be continued for up to three months providing that no side effects are observed including clinical and laboratory surveillance.",
                    "armGroupLabels": [
                        "Polyuric subject secondary to lithium administration",
                        "Polyuric subjects with Autosomal Dominant Polycystic Kidney Disease treated with Tolvaptan",
                        "Polyuric subjects with Hereditary Nephrogenic Diabetes Insipidus"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Change in urine osmolality",
                    "description": "Measured in milliosmoles per kilogram of water (mOsm/kg) from a urine specimen and is a measure of the concentration of osmotically active particles, principally sodium, chloride, potassium, and urea",
                    "timeFrame": "Baseline, 90 days"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Change in urine output",
                    "description": "Measured in milliliters per day (ml/day) by 24 hour urine collection",
                    "timeFrame": "Baseline, day 15, day 45, day 75"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Diagnosis of nephrogenic diabetes insipidus (NDI) (congenital, tolvaptan-induced, or lithium-induced).\n* Morning Uosm \\< 300 mOsm/kg H2O.\n* Participating in tolvaptan arm.\n* Males for NDI.\n* Autosomal Dominant Polycystic Kidney Disease (ADPKD).\n* Lithium-induced NDI.\n* GFR (Glomerular filtration rate) \u2265 30 ml/min.\n* If hypertensive, blood pressure controlled on antihypertensives (\\< 130/80 mm Hg) at least 30 days before day 1.\n* Capable of providing consent.\n* Capable of providing urine samples as dictated by the protocol.\n\nExclusion Criteria:\n\n* History of acute gout attack in the past 30 days.\n* Uncontrolled hyperuricemia or active gout.\n* Known urinary retention, urinary incontinence or bladder dysfunction.\n* Other significant chronic medical disease (heart failure, diabetes mellitus, liver disease, transient or persistent elevated transaminases.\n* History of hepatotoxicity related to tolvaptan.\n* Allergy to interventional drug (PB).\n* History of persistent hyponatremia.",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Trinity Hooks",
                    "role": "CONTACT",
                    "phone": "904-953-3057",
                    "email": "Hooks.Trinity@mayo.edu"
                },
                {
                    "name": "Tia Wilkes",
                    "role": "CONTACT",
                    "phone": "904-953-3636",
                    "email": "Wilkes.Quantia@mayo.edu"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Fouad Chebib, MD",
                    "affiliation": "Mayo Clinic",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "Mayo Clinic",
                    "status": "RECRUITING",
                    "city": "Jacksonville",
                    "state": "Florida",
                    "zip": "32224",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Clinical Studies Unit",
                            "role": "CONTACT",
                            "phone": "904-953-3636",
                            "email": "Wilkes.Quantia@mayo.edu"
                        },
                        {
                            "name": "Trinity Hooks",
                            "role": "CONTACT",
                            "phone": "904-953-3057",
                            "email": "Hooks.Trinity@mayo.edu"
                        },
                        {
                            "name": "Fouad Chebib, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 30.33218,
                        "lon": -81.65565
                    }
                }
            ]
        },
        "referencesModule": {
            "seeAlsoLinks": [
                {
                    "label": "Mayo Clinic Clinical Trials",
                    "url": "https://www.mayo.edu/research/clinical-trials/cls-20525492"
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000007674",
                    "term": "Kidney Diseases"
                },
                {
                    "id": "D000007690",
                    "term": "Polycystic Kidney Diseases"
                },
                {
                    "id": "D000016891",
                    "term": "Polycystic Kidney, Autosomal Dominant"
                },
                {
                    "id": "D000003919",
                    "term": "Diabetes Insipidus"
                },
                {
                    "id": "D000018500",
                    "term": "Diabetes Insipidus, Nephrogenic"
                },
                {
                    "id": "D000003920",
                    "term": "Diabetes Mellitus"
                }
            ],
            "ancestors": [
                {
                    "id": "D000044882",
                    "term": "Glucose Metabolism Disorders"
                },
                {
                    "id": "D000008659",
                    "term": "Metabolic Diseases"
                },
                {
                    "id": "D000004700",
                    "term": "Endocrine System Diseases"
                },
                {
                    "id": "D000014570",
                    "term": "Urologic Diseases"
                },
                {
                    "id": "D000052776",
                    "term": "Female Urogenital Diseases"
                },
                {
                    "id": "D000005261",
                    "term": "Female Urogenital Diseases and Pregnancy Complications"
                },
                {
                    "id": "D000091642",
                    "term": "Urogenital Diseases"
                },
                {
                    "id": "D000052801",
                    "term": "Male Urogenital Diseases"
                },
                {
                    "id": "D000000013",
                    "term": "Congenital Abnormalities"
                },
                {
                    "id": "D000052177",
                    "term": "Kidney Diseases, Cystic"
                },
                {
                    "id": "D000000015",
                    "term": "Abnormalities, Multiple"
                },
                {
                    "id": "D000072661",
                    "term": "Ciliopathies"
                },
                {
                    "id": "D000030342",
                    "term": "Genetic Diseases, Inborn"
                },
                {
                    "id": "D000010900",
                    "term": "Pituitary Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M10698",
                    "name": "Kidney Diseases",
                    "asFound": "Kidney Disease",
                    "relevance": "HIGH"
                },
                {
                    "id": "M7115",
                    "name": "Diabetes Mellitus",
                    "asFound": "Diabetes",
                    "relevance": "HIGH"
                },
                {
                    "id": "M10712",
                    "name": "Polycystic Kidney Diseases",
                    "asFound": "Polycystic Kidney Disease",
                    "relevance": "HIGH"
                },
                {
                    "id": "M19237",
                    "name": "Polycystic Kidney, Autosomal Dominant",
                    "asFound": "Autosomal Dominant Polycystic Kidney",
                    "relevance": "HIGH"
                },
                {
                    "id": "M7114",
                    "name": "Diabetes Insipidus",
                    "asFound": "Diabetes Insipidus",
                    "relevance": "HIGH"
                },
                {
                    "id": "M20603",
                    "name": "Diabetes Insipidus, Nephrogenic",
                    "asFound": "Nephrogenic Diabetes Insipidus",
                    "relevance": "HIGH"
                },
                {
                    "id": "M11639",
                    "name": "Metabolic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M25403",
                    "name": "Glucose Metabolism Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M7862",
                    "name": "Endocrine System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M17319",
                    "name": "Urologic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M2875",
                    "name": "Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M27093",
                    "name": "Female Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M14127",
                    "name": "Pregnancy Complications",
                    "relevance": "LOW"
                },
                {
                    "id": "M8399",
                    "name": "Female Urogenital Diseases and Pregnancy Complications",
                    "relevance": "LOW"
                },
                {
                    "id": "M27095",
                    "name": "Male Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M12",
                    "name": "Congenital Abnormalities",
                    "relevance": "LOW"
                },
                {
                    "id": "M26983",
                    "name": "Kidney Diseases, Cystic",
                    "relevance": "LOW"
                },
                {
                    "id": "M14",
                    "name": "Abnormalities, Multiple",
                    "relevance": "LOW"
                },
                {
                    "id": "M1076",
                    "name": "Ciliopathies",
                    "relevance": "LOW"
                },
                {
                    "id": "M23686",
                    "name": "Genetic Diseases, Inborn",
                    "relevance": "LOW"
                },
                {
                    "id": "M13791",
                    "name": "Pituitary Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "T591",
                    "name": "Autosomal Dominant Multiple Pterygium Syndrome",
                    "asFound": "Autosomal Dominant",
                    "relevance": "HIGH"
                },
                {
                    "id": "T4072",
                    "name": "Nephrogenic Diabetes Insipidus",
                    "asFound": "Nephrogenic Diabetes Insipidus",
                    "relevance": "HIGH"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BXS",
                    "name": "Urinary Tract, Sexual Organs, and Pregnancy Conditions"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC18",
                    "name": "Nutritional and Metabolic Diseases"
                },
                {
                    "abbrev": "BC19",
                    "name": "Gland and Hormone Related Diseases"
                },
                {
                    "abbrev": "BC16",
                    "name": "Diseases and Abnormalities at or Before Birth"
                },
                {
                    "abbrev": "BC10",
                    "name": "Nervous System Diseases"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "browseLeaves": [
                {
                    "id": "M1858",
                    "name": "Tolvaptan",
                    "relevance": "LOW"
                },
                {
                    "id": "M17414",
                    "name": "Vasopressins",
                    "relevance": "LOW"
                },
                {
                    "id": "M4437",
                    "name": "Arginine Vasopressin",
                    "relevance": "LOW"
                },
                {
                    "id": "M19022",
                    "name": "Lithium Carbonate",
                    "relevance": "LOW"
                },
                {
                    "id": "T1",
                    "name": "Arginine",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "NaAg",
                    "name": "Natriuretic Agents"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "VaCoAg",
                    "name": "Vasoconstrictor Agents"
                },
                {
                    "abbrev": "Coag",
                    "name": "Coagulants"
                },
                {
                    "abbrev": "CNSDep",
                    "name": "Central Nervous System Depressants"
                },
                {
                    "abbrev": "PsychDr",
                    "name": "Psychotropic Drugs"
                },
                {
                    "abbrev": "AA",
                    "name": "Amino Acids"
                }
            ]
        }
    },
    "hasResults": false
}